journal article·2016-01

Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(d,l-lactic acid)

Guoying Wang, Yaying Chen, Peng Wang, Yifeng Wang, Hua Hong, Yulin Li, Jiangchao Qian, Yuan Yuan, Bo Yu, Changsheng Liu

Acta Biomaterialia· Volume 29
Publisher page

Abstract

Despite advances in polymeric nanoparticles (NPs) as effective delivery systems for anticancer drugs, rapid clearance from blood and poor penetration capacity in heterogeneous tumors still remain to be addressed. Here, a dual coating of poly (ethylene glycol)-poly (d,l-lactic acid) (PEG-PDLLA) and water-soluble chitosan oligosaccharide (CO) was used to develop PLGA-based NPs (PCPNPs) with colloidal stability for delivery of paclitaxel (PTX). The PCPNPs were prepared by a modified nanoprecipitation process and exhibited homogeneous size of 165.5nm, and slight positive charge (+3.54mV). The single PEG-PDLLA-coated PLGA NPs (PPNPs) with negative charge (-13.42mV) were prepared as control. Human breast cancer MDA-MB-231 cell and mice MDA-MB-231 xenograft model were used for in vitro and in vivo evaluation. Compared to Taxol®, both PCPNPs and PPNPs increased the intracellular uptake and exerted stronger inhibitory effect on tumor cells in vitro, especially for PCPNPs. Particularly, due to the near neutral surface charge and shielding by the dual coating, the blank cationic NP presented low cytotoxicity. With the synergistic action of PEG-PDLLA and CO, PCPNPs not only strongly inhibited macrophage uptake and extended the blood circulation time, but also improved the selective accumulation and interstitial penetration capacity to/in tumor site. Consequently, a significantly enhanced antitumor efficacy was observed for the cationic PCPNPs. Our findings suggest that, the dual PEG-PDLLA/CO coating can effective improve the tumor accumulation and interstitial penetration of NPs and, therefore may have great potential for tumor treatment. Statement of significance Rapid clearance from blood and poor penetration capacity in heterogeneous tumors represent great challenge for polymeric nanoparticles (NPs) as effective delivery systems for anticancer drugs. This study provides a promising cationic nanoparticle (PCPNPs) with dual coating of chitosan oligosaccharide (CO) and PEG-PDLLA to address the above problem. The PCPNPs prepared with 165.5nm and slight positive charge (+3.54mV) showed an improved accumulation and interstitial penetration capacity to/in tumor site, and thus led to an enhanced antitumor efficacy. This is the first time to report the cooperative effect of PEG-PDLLA and CO on PLGA NPs in this field. This work can arouse broad interests among researchers in the fields of nanomedicine, nanotechnology, and drug delivery system.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (43)

Show source-provided references
1. Stimulus-sensitive polymeric nanoparticles and their applications as drug and gene carriers10.1002/adhm.201200313 ↗
2. Biodegradable cationic nanoparticles loaded with an anticancer drug for deep penetration of heterogeneous tumours10.1016/j.biomaterials.2013.06.058 ↗
3. Molecular structure matters: PEG-b-PLA nanoparticles with hydrophilicity and deformability demonstrate their advantages for high-performance delivery of anti-cancer drugs10.1039/c3tb20406e ↗
4. PLGA-based nanoparticles: an overview of biomedical applications10.1016/j.jconrel.2012.01.043 ↗
5. Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation10.1016/j.actbio.2015.01.039 ↗
6. Block copolymer micelles for delivery of cancer therapy: transport at the whole body, tissue and cellular levels10.1016/j.jconrel.2009.04.010 ↗
7. Delivering nanomedicine to solid tumors10.1038/nrclinonc.2010.139 ↗
8. Functionalisation of magnetic nanoparticles for applications in biomedicine10.1088/0022-3727/36/13/203 ↗
9. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles10.1016/j.ijpharm.2005.10.010 ↗
10. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution10.1021/mp800032f ↗
11. The effect of nanoparticle size, shape, and surface chemistry on biological systems10.1146/annurev-bioeng-071811-150124 ↗
12. ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption10.1016/S0927-7765(99)00156-3 ↗
13. Biodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and density10.1023/A:1012248721523 ↗
14. ScFv-Decorated PEG-PLA-based nanoparticles for enhanced siRNA delivery to Her2+ breast cancer10.1002/adhm.201400037 ↗
15. Amphiphilic block co-polymers: preparation and application in nanodrug and gene delivery10.1016/j.actbio.2012.03.006 ↗
16. Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan10.1016/j.biomaterials.2008.12.070 ↗
17. Dual endogenous stimuli-responsive polyplex micelles as smart two-step delivery nanocarriers for deep tumor tissue penetration and combating drug resistance of cisplatin10.1039/C3TB21383H ↗
18. Deeper penetration into tumor tissues and enhanced in vivo antitumor activity of liposomal paclitaxel by pretreatment with angiogenesis inhibitor SU541610.1021/mp300318q ↗
19. Multistage nanoparticle delivery system for deep penetration into tumor tissue10.1073/pnas.1018382108 ↗
20. Effect of antigen turnover rate and expression level on antibody penetration into tumor spheroids10.1158/1535-7163.MCT-08-0067 ↗
21. Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors10.1073/pnas.1018892108 ↗
22. Cationic nanoparticles for cancer therapy10.1517/17425247.2010.485983 ↗
23. A reduction and pH dual-sensitive polymeric vector for long-circulating and tumor-targeted siRNA delivery10.1002/adma.201403877 ↗
24. Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery10.1016/j.biomaterials.2013.01.084 ↗
25. A novel chitosan oligosaccharide–stearic acid micelles for gene delivery: properties and in vitro transfection studies10.1016/j.ijpharm.2006.02.026 ↗
26. Amphiphilically modified chitosan cationic nanoparticles for drug delivery10.1007/s11051-013-2123-2 ↗
27. Effect of zeta potential on the properties of nano-drug delivery systems-a review (Part 2)
28. Biological activities of chitosan and chitooligosaccharides10.1016/j.foodhyd.2010.03.003 ↗
29. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery10.1016/j.ejphar.2011.09.023 ↗
30. Lyoprotected nanosphere formulations for paclitaxel controlled delivery10.1166/jnn.2006.452 ↗
31. Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel10.1016/j.ijpharm.2013.02.004 ↗
32. A novel approach for the preparation of acrylate–siloxane particles with core–shell structure10.1002/pi.2149 ↗
33. Comparison of the PLA-mPEG and mPEG-PLA-mPEG copolymers nanoparticles on the plasma protein adsorption and in vivo biodistribution10.1039/b902714a ↗
34. Surface-charge-dependent cell localization and cytotoxicity of cerium oxide nanoparticles10.1021/nn100816s ↗
35. Nanoparticle therapeutics: an emerging treatment modality for cancer10.1038/nrd2614 ↗
36. Enzymatic production and biological activities of chitosan oligosaccharides (COS): a review10.1016/j.carbpol.2005.08.012 ↗
37. Combinatorial approach in the design of multifunctional polymeric nano-delivery systems for cancer therapy10.1039/C4TB01083C ↗
38. Understanding and overcoming major barriers in cancer nanomedicine10.2217/nnm.10.23 ↗
39. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles10.2147/IJN.S36111 ↗
40. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles10.1016/j.biomaterials.2010.01.065 ↗
41. Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis10.1016/S0939-6411(02)00081-4 ↗
42. Thiol-alkyne chemistry for the preparation of micelles with glycopolymer corona: dendritic surfaces versus linear glycopolymer in their ability to bind to lectins10.1002/marc.201100331 ↗
43. Synthesis of glycopolymers and their multivalent recognitions with lectins10.1039/c0py00141d ↗